ArticleSurgical case reports2022

First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma.

Jiro Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.